TIBER CREEK GROUP for MERCK & CO., INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain; H.R. 5260 - Reduced Costs and Continued Cures Act; issues related to the development of COVID treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
Copyright/Patent/Trademark CPT
S. 1435 - Affordable Prescriptions for Patients Act of 2021; H.R. 2873 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Medicare/Medicaid MMM
H.R. 5376 - Build Back Better, Subtitle J, issues relating to Medicare Part D and Part B Pricing Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
Trade (domestic/foreign) TRD
Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| COREY MALMGREN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.